HOME >> MEDICINE >> NEWS
FDA approves Actonel for once-a-week use

Cincinnati, Ohio; Bridgewater, N.J. (May 20, 2002) - The FDA has approved a new 35 mg once-a-week dosage strength for Actonel (risedronate sodium tablets) for the prevention and treatment of postmenopausal osteoporosis. This approval offers patients the convenience of a once-a-week dosing option to manage their osteoporosis and protect their bones. It will be available in mid-June 2002, by prescription only.

Actonel 35 mg once-a-week is a valuable new tool for the treatment and prevention of postmenopausal osteoporosis, said Robert Lindsay, M.D., Ph.D., Chief of Internal Medicine at Helen Hayes Hospital, Professor of Clinical Medicine, Columbia University, and principal investigator of the Actonel once-a-week approval study. Patients and doctors always welcome effective new treatment choices, and we now have data that show once-a-week dosing of Actonel is therapeutically equivalent to daily 5 mg dosing."

The FDA based its approval on safety and efficacy data from a one-year, double-blind, multicenter study that included 1,456 postmenopausal women with osteoporosis and compared the effects of the once-a-week and daily dosing of Actonel on bone mineral density (BMD). Patients taking Actonel 35 mg once-a-week experienced a significant increase in lumbar spine BMD at 12 months versus baseline -- an increase that was similar to that achieved with the Actonel 5 mg daily dose. There was also a significant increase in BMD versus baseline at the hip at 12 months, an increase that was similar in both treatment groups.

The overall safety and tolerability profiles of Actonel 35 mg once-a-week and 5 mg daily were similar in the study. Consistent with other pivotal Actonel clinical studies, patients were not excluded based on a history of, or active, GI disease.


'"/>

Contact: Ashley Donnelly
adonnelly@hillandknowlton.com
212-885-0488
Hill and Knowlton
20-May-2002


Page: 1

Related medicine news :

1. FDA approves Pfizers Lyrica for the treatment of the two most common forms of neuropathic pain
2. FDA approves Enablex for treatment of overactive bladder
3. FDA approves Fosrenol(R) in end-stage renal disease (ESRD) patients
4. FDA approves Adderall XR (R) to treat ADHD in adults
5. FDA approves EPZICOM
6. FDA approves new labelling for Seroquel in bioplar mania
7. FDA approves Enbrel to treat psoriasis
8. FDA approves Climara Pro to treat menopause symptoms
9. FDA approves new approach to schizophrenia treatment
10. FDA approves new HIV protease inhibitor, Lexiva (TM)
11. FDA approves Wellbutrin XL(TM)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2018)... ... August 17, 2018 , ... An August 7 article ... premature births and low birth weight could be significantly reduced if women were more ... gingivitis (gum disease) which a very large number of pregnant women suffer from to ...
(Date:8/15/2018)... ... August 15, 2018 , ... Today David Hyde Apparel debuts the first, fully ... out of a desire for confidence and comfort year-round, the new shirt leverages a ... in the hottest, most humid of climates. , The brainchild of two recent University ...
(Date:8/14/2018)... MIAMI (PRWEB) , ... August 14, 2018 , ... ... fastest-growing gastroenterology groups, today announced new leadership roles for healthcare executives Simon Frisch ... Division Vice President, Florida, respectively. They assume their roles at a time of ...
(Date:8/11/2018)... ... 10, 2018 , ... Dr. Siavash Eftekhari, Oral and Maxillofacial Surgeon at ... international outpost trip to deliver dental care in impoverished communities. Along with a team ... volunteered his time to help deliver care to over 550 individuals in need. , ...
(Date:8/9/2018)... ... August 09, 2018 , ... Thousands of US ... according to cross-referenced data from The American Society of Plastic Surgeons (ASPS), The ... monitored by the FDA. As an MRI is recommended by FDA after the ...
Breaking Medicine News(10 mins):
(Date:8/7/2018)... ... August 07, 2018 , ... ... of Richard A. Stark to assume the role of Sanarus Technologies President, effective immediately. Mr. ... of strategic development, marketing and sales experience in medical device toward finding new and ...
(Date:8/3/2018)... ... August 03, 2018 , ... In order to improve safety for everyone ... be mindful of the significant risks of injury that many amusement park rides present ... the Ferris wheel or a thrilling ride on a roller coaster. Unfortunately, these fun ...
(Date:8/2/2018)... ... August 02, 2018 , ... Periodontist, Dr. Andres ... crown lengthening treatment at his Eden Prairie, MN practice. Aesthetic crown ... self-conscious. Using decades of experience, Dr. Sanchez is excited to welcome new patients ...
Breaking Medicine Technology:
Cached News: